You are here: Industry Insights > Market News > Unichem gets EIR from US FDA for Goa plant

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

Hot Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

Unichem gets EIR from US FDA for Goa plant

expressbpdJuly 03, 2017

Tag: Goa plant , Unichem , US FDA

Favorites

Unichem Laboratories has received Establishment Inspection Report (EIR) from the US health regulator for the company’s plant at Goa.

The company’s formulations manufacturing facility at Goa has received an EIR from the United States Food and Drug Administration (US FDA), Unichem Laboratories said in a BSE filing.

This receipt indicates successful closure of the inspection and queries raised during the audit, it added.

The inspection that was carried out between March 14-20, 2017 has now been closed by the regulator, the company said.

Previous:Zydus Cadila gets US FDA nod to market anti-obesity drug

Next:Pfizer starts construction of new R&D facility in Missouri, US

New CRO Focused on Cannabis-based Drug Trials Launched

Biotech NewswireMay 23, 2024

Cannovation Clinical Research Partners takes a holistic approach to assist businesses throughout the entire product lifecycle, encompassing product development, commercialization, and launch phases.

InnoCare Announces First Patient Dosed in Clinical Trial of BCL2 Inhibitor ICP-248 in Combination with Orelabrutinib as First-Line Therapy for Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma

PharmaSourcesMay 21, 2024

Selection of Commercial Models for Innovative Drugs

PharmaSourcesMay 21, 2024

Unichem gets EIR from US FDA for Goa plant | Pharmasources.com

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

Biotech NewswireMay 17, 2024

The expanded collaboration includes increasing adoption of the NVIDIA Clara suite of AI-powered computing platforms, software, and services in the Sartorius ecosystem.

Unichem gets EIR from US FDA for Goa plant

Related News

New CRO Focused on Cannabis-based Drug Trials Launched

InnoCare Announces First Patient Dosed in Clinical Trial of BCL2 Inhibitor ICP-248 in Combination with Orelabrutinib as First-Line Therapy for Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma

Selection of Commercial Models for Innovative Drugs

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

You may like